Skip to main content
SpringerLink
Log in

Lidocaine 2% jelly versus lidocaine 2%-sodium hyaluronate 0.3% drops in phacoemulsification surgery

  • Letter to the Editor
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Soliman MM, Macky TA, Samir MK (2004) Comparative clinical trial of topical anesthetic agents in cataract surgery: lidocaine 2% gel, bupivacaine 0.5% drops, and benoxinate 0.4% drops. J Cataract Refract Surg 30:1716–1720

    Article  PubMed  Google Scholar 

  2. Kwok AK, Lai TY, Lee VY, Yeung YS, Chu KO, Pang CC (2006) Effect of application duration of 2% lidocaine jelly on aqueous lidocaine concentration for topical anesthesia in cataract surgery. Graefes Arch Clin Exp Ophthalmol 244:1096–1100

    Article  CAS  PubMed  Google Scholar 

  3. Kalyanasundaram TS, Hasan M (2002) Corneal-wetting property of lignocaine 2% jelly. J Cataract Refract Surg 28:1444–1445

    Article  PubMed  Google Scholar 

  4. Amiel H, Koch PS (2007) Tetracaine hydrochloride 0.5% versus lidocaine 2% jelly as a topical anesthetic agent in cataract surgery: comparative clinical trial. J Cataract Refract Surg 33:98–100

    Article  PubMed  Google Scholar 

  5. Claesson M, Johansson M, Behndig A (2009) Mydriasis with different preparations of topically administered lidocaine hydrochloride. J Cataract Refract Surg 35:277–281

    Article  PubMed  Google Scholar 

  6. AstraZeneca Canada Inc. Xylocaine® Jelly 2% Prescribing Information. Mississauga, Ontario, Canada. Available at: http://www.astrazeneca.ca/documents/ProductPortfolio/XYLOCAINE%20Jelly_PM_en.pdf (Accessed on July 20, 2009)

Download references

Conflict of interest and funding sources

The authors declare no conflict of interest. This is an unfunded study.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Veroia General Hospital, Greece, 28, Papanastasiou Street, Athens, 17342, Greece

    Irini P. Chatziralli & Leonidas Papazisis

  2. School of Medicine, National University of Athens, Athens, Greece

    Theodoros N. Sergentanis

Authors
  1. Irini P. Chatziralli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leonidas Papazisis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Theodoros N. Sergentanis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Irini P. Chatziralli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chatziralli, I.P., Papazisis, L. & Sergentanis, T.N. Lidocaine 2% jelly versus lidocaine 2%-sodium hyaluronate 0.3% drops in phacoemulsification surgery. Graefes Arch Clin Exp Ophthalmol 248, 149–150 (2010). https://doi.org/10.1007/s00417-009-1194-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-009-1194-3

Keywords

Search

Navigation